GastroEsophageal Cancer New Reference: Trastuzumab Deruxtecan for her2+ Gastric Cancer Ulas D. Bayraktar, MD 2025-06-02
GastroEsophageal Cancer New Protocol: TFOX for Advanced Gastric Cancer Ulas D. Bayraktar, MD 2025-05-05
GastroEsophageal Cancer New Protocol: Atezolizumab and Trastuzumab with CapeOx for Periop Her2+ Gastric Cancer Ulas D. Bayraktar, MD 2025-05-04
GastroEsophageal Cancer New Reference: NOTCH1 Mutation as a Predictive Marker for Tislelizumab Ulas D. Bayraktar, MD 2025-04-22
GastroEsophageal Cancer New Reference: Periop FLOT in Esophageal Cancer Ulas D. Bayraktar, MD 2025-01-24
GastroEsophageal Cancer New Drug: Zolbetuximab with FOLFOX for Gastric and GE Junction Cancer Ulas D. Bayraktar, MD 2024-11-11
GastroEsophageal Cancer New Reference: DOCEtaxel, OXALIplatin, Capecitabine in Locally Advanced Gastric Cancer Ulas D. Bayraktar, MD 2023-11-20
GastroEsophageal Cancer New Reference: Pembrolizumab with Chemotherapy in Advanced Gastric Cancer Ulas D. Bayraktar, MD 2023-11-20
GastroEsophageal Cancer New Reference: Trastuzumab Deruxtecan in her2-Positive Advanced Gastroesophageal Cancer Ulas D. Bayraktar, MD 2023-08-20
